• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-212-3p通过靶向ZEB2调控人肝癌上皮-间质转化、迁移和侵袭来抑制紫杉醇耐药。

MicroRNA-212-3p inhibits paclitaxel resistance through regulating epithelial-mesenchymal transition, migration and invasion by targeting ZEB2 in human hepatocellular carcinoma.

作者信息

Yang Jianyu, Cui Ronghua, Liu Yingke

机构信息

Workshop of National TCM Master, Sun Guangrong, The Harmonizing School of TCM, Beijing University of Chinese Medicine, Haikou, Hainan 570208, P.R. China.

Inheritance Workshop in Beijing Hepingli Hospital for National TCM Master, Sun Guangrong, Haikou, Hainan 570208, P.R. China.

出版信息

Oncol Lett. 2020 Oct;20(4):23. doi: 10.3892/ol.2020.11884. Epub 2020 Jul 16.

DOI:10.3892/ol.2020.11884
PMID:32774496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7406882/
Abstract

Hepatocellular carcinoma (HCC) is one of the most common tumor malignances with poor chemotherapeutic efficiency due to chemoresistance. MicroRNAs (miRNAs) have essential roles in regulating chemoresistance. However, the mechanism underlying the involvement of miR-212-3p in paclitaxel (PTX) resistance in HCC remains unclear. PTX resistance was investigated in the present study by assessing cell viability, the half maximal inhibitory concentration of PTX, resistance-associated protein levels and apoptosis. The expression levels of miR-212-3p and zinc finger E-box binding homeobox 2 (ZEB2) were detected by reverse transcription-quantitative PCR and western blotting. The epithelial-mesenchymal transition (EMT), migration and invasion were evaluated by western blotting and transwell assay. The association between miR-212-3p and ZEB2 was investigating by the luciferase activity. The results showed that treatment of HCC cells with PTX inhibited cell viability and miR-212-3p level. Moreover, miR-212-3p was reduced and its overexpression resulted in decreased cell viability, half maximal inhibitory concentration (IC) of PTX and levels of P-glycoprotein and glutathione S-transferase π, but increased cell apoptosis, in Huh7/PTX cells. However, miR-212-3p knockdown induced opposite effects in Huh7 cells. Furthermore, EMT, migration and invasion were induced in Huh7/PTX cells and the addition of miR-212-3p inhibited EMT, migration and invasion. Meanwhile, miR-212-3p abrogation caused the opposite effects in Huh7 cells. Additionally, ZEB2 was directly targeted by miR-212-3p and its restoration or silencing abated the effect of miR-221-3p overexpression or knockdown in Huh7/PTX or Huh7 cells, respectively. The data from the present study suggest that miR-212-3p attenuates PTX resistance, by regulating EMT, migration and invasion via targeting ZEB2 in HCC cells, indicating a novel target for HCC chemotherapy.

摘要

肝细胞癌(HCC)是最常见的肿瘤恶性疾病之一,由于化疗耐药性,其化疗效率较低。微小RNA(miRNA)在调节化疗耐药性中起重要作用。然而,miR-212-3p参与HCC中紫杉醇(PTX)耐药性的潜在机制仍不清楚。本研究通过评估细胞活力、PTX的半数最大抑制浓度、耐药相关蛋白水平和细胞凋亡来研究PTX耐药性。通过逆转录定量PCR和蛋白质印迹法检测miR-212-3p和锌指E盒结合同源框2(ZEB2)的表达水平。通过蛋白质印迹法和Transwell实验评估上皮-间质转化(EMT)、迁移和侵袭。通过荧光素酶活性研究miR-212-3p与ZEB2之间的关联。结果表明,用PTX处理HCC细胞可抑制细胞活力和miR-212-3p水平。此外,在Huh7/PTX细胞中,miR-212-3p水平降低,其过表达导致细胞活力、PTX的半数最大抑制浓度(IC)以及P-糖蛋白和谷胱甘肽S-转移酶π水平降低,但细胞凋亡增加。然而,miR-212-3p敲低在Huh7细胞中诱导相反的效果。此外,Huh7/PTX细胞中诱导了EMT、迁移和侵袭,添加miR-212-3p可抑制EMT、迁移和侵袭。同时,miR-212-3p缺失在Huh7细胞中产生相反的效果。此外,ZEB2是miR-212-3p的直接靶点,其恢复或沉默分别减弱了miR-212-3p过表达或敲低对Huh7/PTX或Huh7细胞的影响。本研究数据表明,miR-212-3p通过靶向ZEB2调节HCC细胞中的EMT、迁移和侵袭,从而减弱PTX耐药性,为HCC化疗指明了一个新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/63278b52adf1/ol-20-04-11884-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/67f35ba19587/ol-20-04-11884-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/92edf0bd40a2/ol-20-04-11884-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/0dbcd1f1c6f0/ol-20-04-11884-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/20a4cd010249/ol-20-04-11884-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/4dbaa9fee751/ol-20-04-11884-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/63278b52adf1/ol-20-04-11884-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/67f35ba19587/ol-20-04-11884-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/92edf0bd40a2/ol-20-04-11884-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/0dbcd1f1c6f0/ol-20-04-11884-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/20a4cd010249/ol-20-04-11884-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/4dbaa9fee751/ol-20-04-11884-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd16/7406882/63278b52adf1/ol-20-04-11884-g05.jpg

相似文献

1
MicroRNA-212-3p inhibits paclitaxel resistance through regulating epithelial-mesenchymal transition, migration and invasion by targeting ZEB2 in human hepatocellular carcinoma.微小RNA-212-3p通过靶向ZEB2调控人肝癌上皮-间质转化、迁移和侵袭来抑制紫杉醇耐药。
Oncol Lett. 2020 Oct;20(4):23. doi: 10.3892/ol.2020.11884. Epub 2020 Jul 16.
2
Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.环状 RNA circ-PVT1 通过海绵吸附 miR-124-3p 调控 ZEB1 表达促进胃癌细胞对紫杉醇耐药。
Biosci Rep. 2019 Dec 20;39(12). doi: 10.1042/BSR20193045.
3
Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.敲低长链非编码 RNA CCAT1 通过调控 miR-24-3p 和 FSCN1 增强前列腺癌对紫杉醇的敏感性。
Cancer Biol Ther. 2020 May 3;21(5):452-462. doi: 10.1080/15384047.2020.1727700. Epub 2020 Feb 23.
4
miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.微小RNA-139-5p通过靶向锌指E盒结合蛋白1和锌指E盒结合蛋白2抑制肝癌细胞的上皮-间质转化、迁移和侵袭。
Biochem Biophys Res Commun. 2015 Jul 31;463(3):315-21. doi: 10.1016/j.bbrc.2015.05.062. Epub 2015 May 27.
5
lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.长链非编码RNA TUG1介导的Mir-142-3p下调通过靶向ZEB1促进肝细胞癌的转移和上皮-间质转化
Cell Physiol Biochem. 2018;48(5):1928-1941. doi: 10.1159/000492517. Epub 2018 Aug 9.
6
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.微小RNA-338-3p通过靶向锌指E盒结合蛋白2以及甲硫氨酸腺苷基转移酶1A/间充质上皮转化因子/蛋白激酶B信号通路抑制胃癌细胞的上皮-间质转化
Oncotarget. 2015 Jun 20;6(17):15222-34. doi: 10.18632/oncotarget.3835.
7
Long non-coding RNA DUXAP8 promotes tumorigenesis by regulating IGF1R via miR-9-3p in hepatocellular carcinoma.长链非编码RNA DUXAP8通过在肝细胞癌中经由miR-9-3p调控IGF1R来促进肿瘤发生。
Exp Ther Med. 2021 Jul;22(1):755. doi: 10.3892/etm.2021.10187. Epub 2021 May 12.
8
miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.微小RNA-590-3p通过靶向锌指E盒结合蛋白1(ZEB1)和锌指E盒结合蛋白2(ZEB2)抑制多形性胶质母细胞瘤中癌细胞的迁移、侵袭和上皮-间质转化。
Biochem Biophys Res Commun. 2015 Dec 25;468(4):739-45. doi: 10.1016/j.bbrc.2015.11.025. Epub 2015 Nov 7.
9
MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.微小RNA-542-3p通过靶向泛素蛋白连接酶E3C抑制肝细胞癌的转移和上皮-间质转化。
Biomed Pharmacother. 2017 Sep;93:420-428. doi: 10.1016/j.biopha.2017.06.070. Epub 2017 Jun 27.
10
MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.微小RNA-370通过靶向GUCD1调控肝细胞癌的上皮-间质转化、迁移、侵袭及预后
Yonsei Med J. 2019 Mar;60(3):267-276. doi: 10.3349/ymj.2019.60.3.267.

引用本文的文献

1
Putative Biomarkers for Prognosis, Epithelial-to-Mesenchymal Transition, and Drug Response in Cell Lines Representing Oral Squamous Cell Carcinoma Progression.代表口腔鳞状细胞癌进展的细胞系中用于预后、上皮-间质转化和药物反应的潜在生物标志物。
Genes (Basel). 2025 Feb 9;16(2):209. doi: 10.3390/genes16020209.
2
CAFs-derived TIAM1 Promotes OSCC Cell Growth and Metastasis by Regulating ZEB2.癌相关成纤维细胞衍生的TIAM1通过调控ZEB2促进口腔鳞状细胞癌细胞生长和转移。
Cell Biochem Biophys. 2025 Mar;83(1):729-740. doi: 10.1007/s12013-024-01505-4. Epub 2024 Sep 10.
3
The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.

本文引用的文献

1
Tumour evolution in hepatocellular carcinoma.肝细胞癌中的肿瘤演进。
Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):139-152. doi: 10.1038/s41575-019-0229-4. Epub 2019 Dec 2.
2
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.微小 RNA 在肝细胞癌主要分子通路中的作用。
World J Gastroenterol. 2018 Jul 7;24(25):2647-2660. doi: 10.3748/wjg.v24.i25.2647.
3
LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.长链非编码 RNA TUG1 通过调控 miR-212-3p/FOXA1 轴促进骨肉瘤细胞增殖并抑制凋亡。
EMT相关非编码RNA调控轴在肝细胞癌中的关键作用。
Front Pharmacol. 2023 Sep 11;14:1270425. doi: 10.3389/fphar.2023.1270425. eCollection 2023.
4
The functions and roles of C2H2 zinc finger proteins in hepatocellular carcinoma.C2H2锌指蛋白在肝细胞癌中的功能与作用。
Front Physiol. 2023 Jun 29;14:1129889. doi: 10.3389/fphys.2023.1129889. eCollection 2023.
5
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.非编码 RNA 与肝癌耐药性的相互作用:小细节的大影响。
J Transl Med. 2023 Jun 7;21(1):369. doi: 10.1186/s12967-023-04238-9.
6
-Glycoproteomics Study of Putative -Glycoprotein Biomarkers of Drug Resistance in MCF-7/ADR Cells.MCF-7/ADR细胞中耐药相关假定糖蛋白生物标志物的糖蛋白质组学研究。
Phenomics. 2021 Oct 28;1(6):269-284. doi: 10.1007/s43657-021-00029-8. eCollection 2021 Dec.
7
Prognostic MicroRNA Fingerprints Predict Recurrence of Early-Stage Hepatocellular Carcinoma Following Hepatectomy.预后微小RNA指纹图谱预测肝切除术后早期肝细胞癌的复发
J Cancer. 2023 Feb 5;14(3):480-489. doi: 10.7150/jca.79593. eCollection 2023.
8
Oncogenic circular RNA circ_0007534 contributes to paclitaxel resistance in endometrial cancer by sponging miR-625 and promoting ZEB2 expression.致癌环状RNA circ_0007534通过吸附miR-625并促进ZEB2表达,导致子宫内膜癌对紫杉醇耐药。
Front Oncol. 2022 Aug 4;12:985470. doi: 10.3389/fonc.2022.985470. eCollection 2022.
9
Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma.非编码RNA介导的肝细胞癌化疗耐药的分子基础
Cancer Cell Int. 2022 Aug 9;22(1):249. doi: 10.1186/s12935-022-02643-6.
10
New Tricks with Old Dogs: Computational Identification and Experimental Validation of New miRNA-mRNA Regulation in hiPSC-CMs.老数据新玩法:人诱导多能干细胞来源心肌细胞中新的微小RNA-信使核糖核酸调控的计算识别与实验验证
Biomedicines. 2022 Feb 6;10(2):391. doi: 10.3390/biomedicines10020391.
Biomed Pharmacother. 2018 Jan;97:1645-1653. doi: 10.1016/j.biopha.2017.12.004. Epub 2017 Dec 8.
4
Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a.缺氧介导的miR-212-3p下调通过上调Rab1a促进肝内胆管癌进展。
Cancer Biol Ther. 2018;19(11):984-993. doi: 10.1080/15384047.2018.1456608. Epub 2018 May 14.
5
Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.耐药性是肝细胞癌化疗的主要障碍:一项深入研究
Cancer Cell Int. 2018 Mar 20;18:44. doi: 10.1186/s12935-018-0538-7. eCollection 2018.
6
miR-212-3p reduced proliferation, and promoted apoptosis of fibroblast-like synoviocytes via down-regulating SOX5 in rheumatoid arthritis.miR-212-3p 通过下调类风湿关节炎成纤维样滑膜细胞中的 SOX5 来减少增殖,并促进细胞凋亡。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):461-471. doi: 10.26355/eurrev_201801_14196.
7
NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.NEK2 通过调节上皮-间充质转化促进肝癌细胞迁移和侵袭。
Oncol Rep. 2018 Mar;39(3):1023-1033. doi: 10.3892/or.2018.6224. Epub 2018 Jan 22.
8
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.
9
hsa-miR-212 modulates the radiosensitivity of glioma cells by targeting BRCA1.hsa-miR-212 通过靶向 BRCA1 调节神经胶质瘤细胞的放射敏感性。
Oncol Rep. 2018 Mar;39(3):977-984. doi: 10.3892/or.2017.6156. Epub 2017 Dec 15.
10
A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.miRNA-200c/组织蛋白酶 L 反馈环路通过调节上皮-间充质转化决定体外人肺癌 A549 细胞对紫杉醇的耐药性。
Acta Pharmacol Sin. 2018 Jun;39(6):1034-1047. doi: 10.1038/aps.2017.164. Epub 2017 Dec 7.